tradingkey.logo
tradingkey.logo
Search

First Tracks Biotherapeutics Ord Shs

TRAX
Add to Watchlist
35.130USD
-1.530-4.17%
Market hours 09/24, 11:58ET
1.23BMarket Cap
0.00P/E TTM

TRAX Financials

See First Tracks Biotherapeutics Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.23B
Dividend TTM
0.00
P/E TTM
0.00
EPS TTM
0.00
Revenue
--
Net Profit
0.00
ROE
0.00%
ROA
0.00%

First Tracks Biotherapeutics Ord Shs Earnings Date

Latest Release
Aug 12, 2026
EPS / Forecast
-0.95/-0.83
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
Financial Indicators
EPS
---0.95
---1.45
Net Profit
---33.37M
---50.48M
Operating profit
---34.94M
---52.81M
Net Profit
---33.37M
---50.48M
Current assets
--177.75M
--289.40M
Total current liabilities
--12.45M
--33.11M
Total assets
--183.14M
--290.58M
Total liabilities
--14.34M
--33.11M
Total equity
--168.80M
--257.46M
Net operating income
---31.92M
---32.56M
Net investment
---25.00K
--34.98M
Net financing
---48.51M
--7.85M

FAQs

What are the current assets of First Tracks Biotherapeutics Ord Shs?

According to First Tracks Biotherapeutics Ord Shs's FY2025 earnings report, its current assets were 316.40M, with a year-on-year change of -18.86.

What are the total assets of First Tracks Biotherapeutics Ord Shs?

According to First Tracks Biotherapeutics Ord Shs's FY2025 earnings report, its total assets of First Tracks Biotherapeutics Ord Shs were 330.55M, with a year-on-year change of -25.20.

What are the total liabilities of First Tracks Biotherapeutics Ord Shs?

According to First Tracks Biotherapeutics Ord Shs's FY2025 earnings report, its total liabilities of First Tracks Biotherapeutics Ord Shs were 43.05M, with a year-on-year change of -14.40.

What is the total equity of First Tracks Biotherapeutics Ord Shs?

According to First Tracks Biotherapeutics Ord Shs's FY2025 earnings report, its total equity of First Tracks Biotherapeutics Ord Shs was 287.49M, with a year-on-year change of -26.59.

What is the net operating income of First Tracks Biotherapeutics Ord Shs?

According to First Tracks Biotherapeutics Ord Shs's FY2025 earnings report, its net operating income of First Tracks Biotherapeutics Ord Shs was -179.01M, with a year-on-year change of 1.16.

What is the net investment of First Tracks Biotherapeutics Ord Shs?

According to First Tracks Biotherapeutics Ord Shs's FY2025 earnings report, its net investment of First Tracks Biotherapeutics Ord Shs was 228.03M, with a year-on-year change of 139.03.

What is the net financing of First Tracks Biotherapeutics Ord Shs?

According to First Tracks Biotherapeutics Ord Shs's FY2025 earnings report, its net financing of First Tracks Biotherapeutics Ord Shs was 30.01M, with a year-on-year change of -74.46.

What is the net income of First Tracks Biotherapeutics Ord Shs?

According to First Tracks Biotherapeutics Ord Shs's FY2025 earnings report, its net income was -166.09M, with a year-on-year change of -1.46.

What is the operating profit of First Tracks Biotherapeutics Ord Shs?

According to First Tracks Biotherapeutics Ord Shs's FY2025 earnings report, its operating profit was -179.01M, with a year-on-year change of 1.16.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.